BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28249571)

  • 21. The relationship between liver function and liver parenchymal contrast enhancement on Gd-BOPTA-enhanced MR imaging in the hepatocyte phase.
    Zhao X; Huang M; Zhu Q; Wang T; Liu Q
    Magn Reson Imaging; 2015 Jul; 33(6):768-73. PubMed ID: 25842259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time
    Haimerl M; Fuhrmann I; Poelsterl S; Fellner C; Nickel MD; Weigand K; Dahlke MH; Verloh N; Stroszczynski C; Wiggermann P
    Eur Radiol; 2018 Sep; 28(9):3591-3600. PubMed ID: 29532241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
    Haimerl M; Schlabeck M; Verloh N; Zeman F; Fellner C; Nickel D; Barreiros AP; Loss M; Stroszczynski C; Wiggermann P
    Eur Radiol; 2016 Apr; 26(4):1125-33. PubMed ID: 26186960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance.
    Sheng RF; Wang HQ; Yang L; Jin KP; Xie YH; Fu CX; Zeng MS
    Dig Liver Dis; 2017 Jul; 49(7):789-795. PubMed ID: 28237298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Hepatol Int; 2015 Apr; 9(2):303-9. PubMed ID: 25788184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
    Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
    Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-contrast T1ρ dispersion versus Gd-EOB-DTPA-enhanced T1mapping for the risk stratification of non-alcoholic fatty liver disease in rabbit models.
    Yang R; Chen Z; Pan J; Yang S; Hu F
    Magn Reson Imaging; 2024 Apr; 107():130-137. PubMed ID: 38278311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.
    Tamada T; Ito K; Higaki A; Yoshida K; Kanki A; Sato T; Higashi H; Sone T
    Eur J Radiol; 2011 Dec; 80(3):e311-6. PubMed ID: 21315529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application Progress of Gd-EOB-DTPA-Enhanced MRI T1 Mapping in Hepatic Diffuse Diseases.
    Wen X; Feng X; Kang Y; Xu L
    Curr Med Imaging; 2022; 18(12):1276-1281. PubMed ID: 34847846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function.
    Besa C; Bane O; Jajamovich G; Marchione J; Taouli B
    Magn Reson Imaging; 2015 Nov; 33(9):1075-1082. PubMed ID: 26119422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1 reduction rate with Gd-EOB-DTPA determines liver function on both 1.5 T and 3 T MRI.
    Obmann VC; Catucci D; Berzigotti A; Gräni C; Ebner L; Heverhagen JT; Christe A; Huber AT
    Sci Rep; 2022 Mar; 12(1):4716. PubMed ID: 35304554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
    Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
    Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing Liver Function by T1 Maps on Gd-EOB-DTPA-Enhanced MRI for up to 50 Min in Rat Models of Liver Fibrosis: A Longer Hepatobiliary Time Period may Help.
    Xu J; Wang X; Jin ZY; Wang Q; You Y; Wang ST; Qian TY; Xue HD
    Chin Med Sci J; 2021 Jun; 36(2):110-119. PubMed ID: 34231459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of Imaging-Based Quantitative Hepatic Function Assessment: Gd-EOB-DTPA-Enhanced Liver MR Imaging Combined with T1 Mapping.
    Dong Z; Wang M; Feng Y; Cai H; Feng ST; Li ZP; Lin Z; Peng Z
    Curr Med Imaging; 2023; 19(12):1394-1403. PubMed ID: 36642881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of liver function using the hepatocyte enhancement fraction based on gadoxetic acid-enhanced MRI in patients with chronic hepatitis B.
    Liu MT; Zhang XQ; Lu J; Zhang T; Chen Q; Jiang JF; Ding D; Du S; Chen WB
    Abdom Radiol (NY); 2020 Oct; 45(10):3129-3135. PubMed ID: 32185444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.